Your browser doesn't support javascript.
loading
Discovery of triazenyl triazoles as Nav1.1 channel blockers for treatment of epilepsy.
Zhou, Xianjing; Zeng, Linwei; Wang, Yi; Xu, Cenglin; Chen, Zhong; Cui, Sunliang.
Afiliação
  • Zhou X; Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
  • Zeng L; Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
  • Wang Y; Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
  • Xu C; Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
  • Chen Z; Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
  • Cui S; Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. Electronic address: slcui@zju.edu.cn.
Bioorg Med Chem Lett ; 75: 128946, 2022 11 01.
Article em En | MEDLINE | ID: mdl-35985458

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pentilenotetrazol / Epilepsia Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pentilenotetrazol / Epilepsia Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article